FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
US FDA puts clinical hold on Atara's trials for cancer cell therapies
Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell ...
Trump Order Walks Back Biden-Era Effort To Lower Prescription Drug Prices. Here's Context
Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...
BusinessMirror13h
US FDA removes coconut from food allergen list–PCA
The exclusion of coconut as a major food allergen eases trade barriers for coconut-based products in the US market, according to the Philippine Coconut Authority (PCA). This, after the US Food and ...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
cnbctv1813h
Laurus Labs' US arm gets Form 483 from FDA after 'adverse experience' probe
The inspection focused on the subsidiary's practices and procedures related to Laurus Labs’ marketed products worldwide.
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...
Trump Officials Ask US Health Agencies to Pause External Communications, Washington Post Reports
The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications ...